Excess weight mediates changes in HDL pool that reduce cholesterol efflux capacity and increase antioxidant activity
Authors:
- Jose Carlos de Lima-JuniorJLJose Carlos de Lima-Junior
- Vitor W.M. VirginioVVVitor W.M. Virginio
- Filipe A. MouraFMFilipe A. Moura
- Adriana BertolamiABAdriana Bertolami
- Marcelo BertolamiMBMarcelo Bertolami
- Otavio R Coelho-FilhoOCOtavio R Coelho-Filho
- Ilaria ZanottiIlaria Zanotti
- Wilson NadruzWNWilson Nadruz
- Eliana Cotta de FariaEFEliana Cotta de Faria
- Luiz Sergio F. de CarvalhoLCLuiz Sergio F. de Carvalho
- Andrei C SpositoASAndrei C Sposito
Preprint
Abstract
Objective: Obesity-related decline in high-density lipoprotein (HDL) functions such as cholesterol efflux capacity (CEC) has supported the notion that this lipoprotein dysfunction may contribute for atherogenesis among obese patients. Besides, potentially other HDL protective actions may be affected with weight gain and these changes may occur even before the obesity range. Methods: Lipid profile, body mass index (BMI), biochemical measurements, and carotid intima-media thickness (cIMT) were obtained in this cross-sectional study with 899 asymptomatic individuals. HDL functions were measured in a subgroup (n=101). Results: Individuals with increased HDL-C had an attenuated increase in cIMT with elevation of BMI. CEC, HDL-C, HDL size and HDL-antioxidant activity were negatively associated with cIMT. BMI was inversely associated with HDL-mediated inhibition of platelet aggregation and CEC, but surprisingly it was directly associated with the antioxidant activity. Thus, even in non-obese, non-diabetic individuals, increased BMI is associated with a wide change in protective functions of HDL, reducing CEC and increasing antioxidant activity. In these subjects, decreased HDL concentration, size or function are related to increased atherosclerotic burden. Conclusion: Our findings demonstrate that in non-obese, non-diabetic individuals, the increasing values of BMI are associated with impaired protective functions of HDL and concomitant increase in atherosclerotic burden.Keywords
All Related Versions
- Published version: Nutrition, Metabolism and Cardiovascular Diseases, 30 (2), 254.
This publication has 36 references indexed in Scilit:
- Platelet activation in obesity and metabolic syndromeObesity Reviews, 2011
- Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery diseaseJournal of Clinical Investigation, 2011
- Impact of android overweight or obesity and insulin resistance on basal and postprandial SR-BI and ABCA1-mediated serum cholesterol efflux capacitiesAtherosclerosis, 2010
- Oxidized high-density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BIBlood, 2008
- Use of Carotid Ultrasound to Identify Subclinical Vascular Disease and Evaluate Cardiovascular Disease Risk: A Consensus Statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force Endorsed by the Society for Vascular MedicineJournal of the American Society of Echocardiography, 2008
- Carotid Intima-Media Thickening Indicates a Higher Vascular Risk Across a Wide Age RangeStroke, 2006
- Determination of human plasma phospholipid transfer protein mass and activityMethods, 2005
- Rapid, Simple Laser-Light-Scattering Method for HDL Particle Sizing in Whole PlasmaClinical Chemistry, 2004
- Small, Dense HDL Particles Exert Potent Protection of Atherogenic LDL Against Oxidative StressArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Increased plasma cholesteryl ester transfer protein in obese subjects. A possible mechanism for the reduction of serum HDL cholesterol levels in obesity.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994